322
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Risk of Emerging Resistance to Trimethoprim/Sulfamethoxazole in Staphylococcus aureus

ORCID Icon, , ORCID Icon &
Pages 4779-4784 | Published online: 23 Aug 2022

References

  • DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated methicillin-resistant Staphylococcus aureus. Lancet. 2010;375:1557–1568. doi:10.1016/S0140-6736(09)61999-1
  • David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23:616–687. doi:10.1128/CMR.00081-09
  • Algammal AM, Hetta HF, Elkelish A, et al. Methicillin-Resistant Staphylococcus aureus (MRSA): one health perspective approach to the bacterium epidemiology, virulence factors, antibiotic-resistance, and zoonotic impact. Infect Drug Resist. 2020;13:3255–3265. doi:10.2147/IDR.S272733
  • Spengler G, Gajdács M, Donadu MG, et al. Evaluation of the antimicrobial and antivirulent potential of essential oils isolated from Juniperus oxycedrus L. ssp. macrocarpa aerial parts. Microorganisms. 2022;10(4):758. doi:10.3390/microorganisms10040758
  • Mazzarello V, Gavini E, Rassu G, et al. Clinical assessment of new topical cream containing two essential oils combined with tretinoin in the treatment of acne. Clin Cosmet Investig Dermatol. 2020;13:233–239. doi:10.2147/CCID.S236956
  • Bua A, Usai D, Donadu MG, et al. Antimicrobial activity of Austroeupatorium inulaefolium (H.B.K.) against intracellular and extracellular organisms. Nat Prod Res. 2018;32:2869–2871. doi:10.1080/14786419.2017.1385014
  • Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18–e55. doi:10.1093/cid/ciq146
  • Spellberg B, Lipsky BA. Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infect Dis. 2012;54:393–407. doi:10.1093/cid/cir842
  • Paul M, Bishara J, Yahav D, et al. Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial. BMJ. 2015;350:h2219. doi:10.1136/bmj.h2219
  • Schmitz GR, Bruner D, Pitotti R, et al. Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. Ann Emerg Med. 2010;56:283–287. doi:10.1016/j.annemergmed.2010.03.002
  • Dale GE, Broger C, D’Arcy A, et al. A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance. J Mol Biol. 1997;266:23–30. doi:10.1006/jmbi.1996.0770
  • Nurjadi D, Olalekan AO, Layer F, et al. Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe. J Antimicrob Chemother. 2014;69:2361–2368. doi:10.1093/jac/dku174
  • Clinical and Laboratory Standards Institute. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. CLSI Guideline M45. 3rd ed. Wayne, PA: CLSI; 2016.
  • Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100. 28th ed. Wayne, PA: CLSI; 2018.
  • Berti AD, Wergin JE, Girdaukas GG, Hetzel SJ, Sakoulas G, Rose WE. Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics. Antimicrob Agents Chemother. 2012;56:5046–5053. doi:10.1128/AAC.00502-12
  • Dale GE, Then RL, Stüber D. Characterization of the gene for chromosomal trimethoprim-sensitive dihydrofolate reductase of Staphylococcus aureus ATCC 25923. Antimicrob Agents Chemother. 1993;37:1400–1405. doi:10.1128/AAC.37.7.1400
  • Saito M, Katayama Y, Hishinuma T, et al. “Slow VISA”, a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3. Antimicrob Agents Chemother. 2014;58:5024–5035. doi:10.1128/AAC.02470-13
  • Sader HS, Mendes RE, Streit JM, Flamm RK. Antimicrobial susceptibility trends among staphylococcus aureus isolates from U.S. hospitals: results from 7 years of the ceftaroline (AWARE) surveillance program, 2010 to 2016. Antimicrob Agents Chemother. 2017;61:e01043–17. doi:10.1128/AAC.01043-17
  • Watanabe S, Ohnishi T, Yuasa A, et al. The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan. J Infect Chemother. 2017;23:503–511. doi:10.1016/j.jiac.2017.05.006
  • Kavanagh N, Ryan EJ, Widaa A, et al. Staphylococcal osteomyelitis: disease progression, treatment challenges, and future directions. Clin Microbiol Rev. 2018;31:e00084–17. doi:10.1128/CMR.00084-17
  • Song LY, Goff M, Davidian C, et al. Mutational consequences of ciprofloxacin in Escherichia coli. Antimicrob Agents Chemother. 2016;60:6165–6172. doi:10.1128/AAC.01415-16
  • Ward WO, Swartz CD, Hanley NM, DeMarini DM. Transcriptional characterization of Salmonella TA100 in log and stationary phase: influence of growth phase on mutagenicity of MX. Mut Res. 2010;692:19–25. doi:10.1016/j.mrfmmm.2010.07.010
  • Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387:176–187. doi:10.1016/S0140-6736(15)00473-0
  • Durão P, Balbontín R, Gordo I. Evolutionary mechanisms shaping the maintenance of antibiotic resistance. Trends Microbiol. 2018;26:677–691.
  • Aires de Sousa M, Crisóstomo MI, Sanches IS, et al. Frequent recovery of a single clonal type of multidrug-resistant Staphylococcus aureus from patients in two hospitals in Taiwan and China. J Clin Microbiol. 2003;41:159–163. doi:10.1128/JCM.41.1.159-163.2003
  • Breurec S, Fall C, Pouillot R, et al. Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton-Valentine leukocidin genes. Clin Microbiol Infect. 2011;17:633–639. doi:10.1111/j.1469-0691.2010.03320.x
  • Olalekan AO, Schaumburg F, Nurjadi D, et al. Clonal expansion accounts for an excess of antimicrobial resistance in Staphylococcus aureus colonising HIV-positive individuals in Lagos, Nigeria. Int J Antimicrob Agents. 2012;40:268–272. doi:10.1016/j.ijantimicag.2012.05.016
  • Coelho C, de Lencastre H, Aires-de-Sousa M. Frequent occurrence of trimethoprim-sulfamethoxazole hetero-resistant Staphylococcus aureus isolates in different African countries. Eur J Clin Microbiol Infect Dis. 2017;36:1243–1252. doi:10.1007/s10096-017-2915-x
  • Donadu MG, Ferrari M, Mazzarello V, et al. No correlation between biofilm-forming capacity and antibiotic resistance in environmental Staphylococcus spp. In Vitro Results Pathogens. 2022;11:471. doi:10.3390/pathogens11040471
  • Giacinti G, Carfora V, Caprioli A, et al. Prevalence and characterization of methicillin-resistant Staphylococcus aureus carrying mecA or mecC and methicillin-susceptible Staphylococcus aureus in dairy sheep farms in central Italy. J Dairy Sci. 2017;100:7857–7863. doi:10.3168/jds.2017-12940
  • Sato T, Kawamura M, Furukawa E, Fujimura S. Screening method for trimethoprim/sulfamethoxazole-resistant small colony variants of Staphylococcus aureus. J Glob Antimicrob Resist. 2018;15:1–5. doi:10.1016/j.jgar.2018.05.008